The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design

T. J. Schroeder; L. W. Moore; L. W. Gaber; A. O. Gaber; M. R. First

doi:10.1016/S0041-1345(99)00092-5

The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design

T. J. Schroeder, L. W. Moore, L. W. Gaber, A. O. Gaber, M. R. First

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1S-6S
Journal	Transplantation Proceedings
Volume	31
Issue number	3 SUPPL. 2
DOIs	https://doi.org/10.1016/S0041-1345(99)00092-5
State	Published - May 1999

ASJC Scopus subject areas

Surgery
Transplantation

Access to Document

10.1016/S0041-1345(99)00092-5

Cite this

Schroeder, T. J., Moore, L. W., Gaber, L. W., Gaber, A. O., & First, M. R. (1999). The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design. Transplantation Proceedings, 31(3 SUPPL. 2), 1S-6S. https://doi.org/10.1016/S0041-1345(99)00092-5

The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design. / Schroeder, T. J.; Moore, L. W.; Gaber, L. W. et al.
In: Transplantation Proceedings, Vol. 31, No. 3 SUPPL. 2, 05.1999, p. 1S-6S.

Research output: Contribution to journal › Article › peer-review

Schroeder, TJ, Moore, LW , Gaber, LW , Gaber, AO & First, MR 1999, 'The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design', Transplantation Proceedings, vol. 31, no. 3 SUPPL. 2, pp. 1S-6S. https://doi.org/10.1016/S0041-1345(99)00092-5

@article{5674616b443b4c27b4cc83e3eb960ee7,

title = "The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design",

author = "Schroeder, {T. J.} and Moore, {L. W.} and Gaber, {L. W.} and Gaber, {A. O.} and First, {M. R.}",

year = "1999",

month = may,

doi = "10.1016/S0041-1345(99)00092-5",

language = "English (US)",

volume = "31",

pages = "1S--6S",

journal = "Transplantation Proceedings",

issn = "0041-1345",

publisher = "Elsevier",

number = "3 SUPPL. 2",

}

TY - JOUR

T1 - The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation

T2 - Rationale for study design

AU - Schroeder, T. J.

AU - Moore, L. W.

AU - Gaber, L. W.

AU - Gaber, A. O.

AU - First, M. R.

PY - 1999/5

Y1 - 1999/5

UR - http://www.scopus.com/inward/record.url?scp=0032949785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032949785&partnerID=8YFLogxK

U2 - 10.1016/S0041-1345(99)00092-5

DO - 10.1016/S0041-1345(99)00092-5

M3 - Article

C2 - 10330958

AN - SCOPUS:0032949785

SN - 0041-1345

VL - 31

SP - 1S-6S

JO - Transplantation Proceedings

JF - Transplantation Proceedings

IS - 3 SUPPL. 2

ER -

The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this